Your browser doesn't support javascript.
loading
Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials.
Oostvogels, Lidia; Heineman, Thomas C; Johnson, Robert W; Levin, Myron J; McElhaney, Janet E; Van den Steen, Peter; Zahaf, Toufik; Dagnew, Alemnew F; Chlibek, Roman; Diez-Domingo, Javier; Gorfinkel, Iris S; Hervé, Caroline; Hwang, Shinn-Jang; Ikematsu, Hideyuki; Kalema, George; Lal, Himal; McNeil, Shelly A; Mrkvan, Tomas; Pauksens, Karlis; Smetana, Jan; Watanabe, Daisuke; Weckx, Lily Yin; Cunningham, Anthony L.
Afiliação
  • Oostvogels L; GSK, Wavre, Belgium.
  • Heineman TC; GSK, King of Prussia, PA, USA.
  • Johnson RW; Faculty of Health Sciences, University of Bristol, Bristol, UK.
  • Levin MJ; Departments of Pediatrics and Medicine, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
  • McElhaney JE; Health Sciences North Research Institute, Sudbury, Ontario, Canada.
  • Van den Steen P; GSK, Wavre, Belgium.
  • Zahaf T; GSK, Wavre, Belgium.
  • Dagnew AF; GSK, Rockville, MD, USA.
  • Chlibek R; Faculty of Military Health Sciences, University of Defense, Hradec Kralove, Czech Republic.
  • Diez-Domingo J; Fundación para el Fomento de la Investigación Sanitaria y Biomédica, Valencia, Spain.
  • Gorfinkel IS; PrimeHealth Clinical Research, Toronto, Ontario, Canada.
  • Hervé C; GSK, Wavre, Belgium.
  • Hwang SJ; Department of Family Medicine, Taipei Veterans General Hospital and National Yang Ming University School of Medicine, Taipei, Taiwan.
  • Ikematsu H; Japan Physicians Association, Tokyo, Japan.
  • Kalema G; Keyrus Biopharma, Waterloo, Belgium, on behalf of GSK.
  • Lal H; GSK, King of Prussia, PA, USA.
  • McNeil SA; Canadian Center for Vaccinology, IWK Health Center and Nova Scotia Health Authority, Dalhousie, University, Halifax, Canada.
  • Mrkvan T; GSK, Wavre, Belgium.
  • Pauksens K; Department of Infectious Diseases, Uppsala University Hospital, Uppsala, Sweden.
  • Smetana J; Faculty of Military Health Sciences, University of Defense, Hradec Kralove, Czech Republic.
  • Watanabe D; Department of Dermatology, Aichi Medical University, Nagakute, Japan.
  • Weckx LY; Department of Pediatrics, Federal University of Sao Paulo, Sao Paulo, Brazil.
  • Cunningham AL; The Westmead Institute for Medical Research, Westmead, University of Sydney, Sydney, NSW, Australia.
Hum Vaccin Immunother ; 15(12): 2865-2872, 2019.
Article em En | MEDLINE | ID: mdl-31216205
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_enfermedades_transmissibles Assunto principal: Neuralgia Pós-Herpética / Vacina contra Herpes Zoster / Potência de Vacina / Herpes Zoster Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hum Vaccin Immunother Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_enfermedades_transmissibles Assunto principal: Neuralgia Pós-Herpética / Vacina contra Herpes Zoster / Potência de Vacina / Herpes Zoster Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hum Vaccin Immunother Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Bélgica